These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22821049)

  • 41. Dent Disease with mutations in OCRL1.
    Hoopes RR; Shrimpton AE; Knohl SJ; Hueber P; Hoppe B; Matyus J; Simckes A; Tasic V; Toenshoff B; Suchy SF; Nussbaum RL; Scheinman SJ
    Am J Hum Genet; 2005 Feb; 76(2):260-7. PubMed ID: 15627218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Investigation and OCRL mutation analysis of a family with oculocerebrorenal syndrome of Lowe].
    Shi RM; Bian XH; Li LM; Liu XH
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr; 16(4):366-9. PubMed ID: 24750831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel OCRL mutations in Chinese children with Lowe syndrome.
    Zhang YQ; Wang F; Ding J; Yan H; Yang YL
    World J Pediatr; 2013 Feb; 9(1):53-7. PubMed ID: 23389333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A structural basis for Lowe syndrome caused by mutations in the Rab-binding domain of OCRL1.
    Hou X; Hagemann N; Schoebel S; Blankenfeldt W; Goody RS; Erdmann KS; Itzen A
    EMBO J; 2011 Apr; 30(8):1659-70. PubMed ID: 21378754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of missense mutations in the RhoGAP-homology domain on ocrl1 function.
    Lichter-Konecki U; Farber LW; Cronin JS; Suchy SF; Nussbaum RL
    Mol Genet Metab; 2006; 89(1-2):121-8. PubMed ID: 16777452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of Ocrl1 in primary cilia assembly.
    Madhivanan K; Ramadesikan S; Aguilar RC
    Int Rev Cell Mol Biol; 2015; 317():331-47. PubMed ID: 26008789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. OCRL localizes to the primary cilium: a new role for cilia in Lowe syndrome.
    Luo N; West CC; Murga-Zamalloa CA; Sun L; Anderson RM; Wells CD; Weinreb RN; Travers JB; Khanna H; Sun Y
    Hum Mol Genet; 2012 Aug; 21(15):3333-44. PubMed ID: 22543976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complete oculocerebrorenal phenotype of Lowe syndrome in a female patient with half reduction of inositol polyphosphate 5-phosphatase.
    Yamamoto K; Hasegawa Y; Ohata Y; Satomura K; Mizoguchi Y; Shimotsuji T; Yamamoto T
    CEN Case Rep; 2020 May; 9(2):95-100. PubMed ID: 31707643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. OCRL mutation analysis in Italian patients with Lowe syndrome.
    Addis M; Loi M; Lepiani C; Cau M; Melis MA
    Hum Mutat; 2004 May; 23(5):524-5. PubMed ID: 15108291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Whole-genome sequencing revealed an interstitial deletion encompassing OCRL and SMARCA1 gene in a patient with Lowe syndrome.
    Zheng B; Chen Q; Wang C; Zhou W; Chen Y; Ding G; Jia Z; Zhang A; Huang S
    Mol Genet Genomic Med; 2019 Sep; 7(9):e876. PubMed ID: 31376231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease.
    Festa BP; Berquez M; Gassama A; Amrein I; Ismail HM; Samardzija M; Staiano L; Luciani A; Grimm C; Nussbaum RL; De Matteis MA; Dorchies OM; Scapozza L; Wolfer DP; Devuyst O
    Hum Mol Genet; 2019 Jun; 28(12):1931-1946. PubMed ID: 30590522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.
    De Matteis MA; Staiano L; Emma F; Devuyst O
    Nat Rev Nephrol; 2017 Aug; 13(8):455-470. PubMed ID: 28669993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of OCRL increases ciliary PI(4,5)P
    Prosseda PP; Luo N; Wang B; Alvarado JA; Hu Y; Sun Y
    J Cell Sci; 2017 Oct; 130(20):3447-3454. PubMed ID: 28871046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atypical phenotypes and novel OCRL variations in southern Chinese patients with Lowe syndrome.
    Du R; Zhou C; Chen S; Li T; Lin Y; Xu A; Huang Y; Mei H; Huang X; Tan D; Zheng R; Liang C; Cai Y; Shao Y; Zhang W; Liu L; Zeng C
    Pediatr Nephrol; 2024 Aug; 39(8):2377-2391. PubMed ID: 38589698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Onset mechanism of a female patient with Dent disease 2.
    Okamoto T; Sakakibara N; Nozu K; Takahashi T; Hayashi A; Sato Y; Nagano C; Matsuo M; Iijima K; Manabe A
    Clin Exp Nephrol; 2020 Oct; 24(10):946-954. PubMed ID: 32666344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The oculocerebrorenal syndrome of Lowe: an update.
    Bökenkamp A; Ludwig M
    Pediatr Nephrol; 2016 Dec; 31(12):2201-2212. PubMed ID: 27011217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy.
    Bothwell SP; Chan E; Bernardini IM; Kuo YM; Gahl WA; Nussbaum RL
    J Am Soc Nephrol; 2011 Mar; 22(3):443-8. PubMed ID: 21183592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of two novel mutations in the OCRL1 gene in two Chinese families with Lowe syndrome.
    Ke YH; He JW; Fu WZ; Zhang ZL
    Nephrology (Carlton); 2012 Jan; 17(1):20-5. PubMed ID: 21854507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome.
    Rendu J; Montjean R; Coutton C; Suri M; Chicanne G; Petiot A; Brocard J; Grunwald D; Pietri Rouxel F; Payrastre B; Lunardi J; Dorseuil O; Marty I; Fauré J
    Hum Mutat; 2017 Feb; 38(2):152-159. PubMed ID: 27790796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal manifestations of Dent disease and Lowe syndrome.
    Cho HY; Lee BH; Choi HJ; Ha IS; Choi Y; Cheong HI
    Pediatr Nephrol; 2008 Feb; 23(2):243-9. PubMed ID: 18038239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.